Legislation and Legislative Advocacy
The American Hospital Association (AHA) shares resources on health care legislation being considered by the U.S. House and Senate and legislative advocacy opportunities for hospitals and health systems.
The AHA today expressed support for bipartisan legislation that would expand access to treatment of mental illnesses and substance use disorders through community-based clinics.
Reps. Rosa DeLauro, D-Conn., and Jan Schakowsky, D-Ill., this week introduced the Medicare for America Act, legislation that would create a national health insurance program for most Americans.
The AHA yesterday announced support for the Opioid Workforce Act of 2019, bipartisan legislation to reduce the nation’s shortage of opioid treatment providers by increasing the number of resident physician slots in hospitals with programs focused on substance use disorder treatment.
The House Judiciary Committee yesterday approved by voice vote the Creating and Restoring Equal Access to Equivalent Samples Act (H.R. 965).
The House Appropriations Subcommittee on Labor, Health and Human Services, and Education last night approved legislation that would provide $189.8 billion in discretionary funding for the departments of Labor, HHS and Education and related agencies in fiscal year 2020.
The House Appropriations Committee yesterday released draft legislation that would provide $189.8 billion in discretionary funding for the departments of Labor, Health and Human Services, Education and related agencies in fiscal year 2020.
The Washington state legislature Saturday approved legislation to create a public option on the state’s health insurance exchange by 2021.
Statement
of the
American Hospital Association
for the
Committee on Rules
of the
U.S. House of Representatives
“Medicare for All Act of 2019”
April 30, 2019
The Montana legislature last week passed legislation funding Medicaid coverage for low-income adults for six more years.
The AHA today voiced support for the Recovering Excessive Funds for Unused and Needless Drugs Act (S. 551), legislation that would incentivize manufacturers to align package sizes with common dosage amounts.